Clinical Trial Update: Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating safety and efficacy of empagliflozin in Pakistani Muslim population with Type II diabetes mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Getz Pharma | Conditions: Type II Diabetes Mellitus | Phase 4 | Status: COMPLETED